Quantum dots (QDs) represent a groundbreaking advancement in the field of nanotechnology, particularly within the realm of imaging. These nanoscale semiconductor particles, typically ranging between 2 to 10 nanometres in diameter, possess unique optical and electronic properties that have opened new frontiers in various imaging applications, from biomedical research to advanced display technologies.
At the heart of quantum dots’ remarkable capabilities lies the principle of quantum confinement. Due to their minuscule size, quantum dots exhibit size-tunable photoluminescence, meaning they can emit light of specific wavelengths (colours) based on their size. Smaller dots emit blue light, while larger dots emit red. This characteristic is crucial for their application in imaging, as it allows for precise control over the emitted light’s properties.
One of the most promising applications of quantum dots is in biomedical imaging. Traditional fluorescent dyes, used in various imaging techniques, often suffer from photobleaching and limited spectral properties. Quantum dots, however, offer several advantages. Firstly, they are highly resistant to photobleaching, making them ideal for long-term imaging studies. Secondly, their broad absorption and narrow emission spectra allow for the simultaneous excitation of multiple quantum dots and detection of distinct emission colours, facilitating multiplexed imaging. Thirdly, quantum dots provide bright and high-contrast images, which is essential for detecting minute biological structures and processes. In practice, quantum dots can be conjugated with biomolecules such as antibodies or peptides, enabling targeted imaging of specific cellular components or tissues. For instance, quantum dot-labelled antibodies can bind to cancer biomarkers, allowing for the precise imaging of tumour cells.
Quantum dots are also making significant strides in diagnostic imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). By serving as contrast agents, quantum dots enhance the resolution and sensitivity of these imaging modalities. Their ability to be functionalised with various targeting ligands further improves the specificity of these diagnostic tools, aiding in the early detection and accurate diagnosis of diseases.
Beyond the biomedical field, quantum dots have revolutionised display technology. Quantum dot light-emitting diodes (QLEDs) are being integrated into modern displays, offering superior colour accuracy, brightness, and energy efficiency compared to traditional liquid crystal displays (LCDs) and organic light-emitting diodes (OLEDs). The tunable emission properties of quantum dots allow for the production of displays with a wider colour gamut and enhanced visual quality, significantly improving the viewer experience.
The future of quantum dots in imaging looks promising, with continuous innovations aimed at improving their properties and expanding their applications. Advances in quantum dot synthesis, surface functionalisation, and integration with other nanomaterials are expected to further enhance their performance and versatility.
Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.
